Division of Urologic Surgery

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Nephrectomy 65%
3. Prostate 48%
4. Kidney 44%
5. Prostatectomy 42%
6. Robotics 40%
7. Prostate-Specific Antigen 31%
8. Urinary Bladder 31%
9. Neoplasms 30%
10. Dutasteride 30%
11. Urinary Bladder Neoplasms 26%
12. Biopsy 26%
13. Cystectomy 25%
14. Pelvic Pain 23%
15. Renal Cell Carcinoma 23%
16. Lower Urinary Tract Symptoms 23%
17. Early Detection of Cancer 19%
18. Chronic Pain 18%
19. Interstitial Cystitis 18%
20. Prostatic Hyperplasia 17%
21. Therapeutics 16%
22. Watchful Waiting 13%
23. Overactive Urinary Bladder 12%
24. Survival 12%
25. Pain 12%
26. Carcinoma 11%
27. Surgeons 11%
28. Ovarian Neoplasms 10%
29. Urinary Incontinence 10%
30. Swine 10%
31. Laparoscopy 9%
32. Recurrence 9%
33. Lung Neoplasms 9%
34. Urinary Tract 9%
35. Finasteride 9%
36. Operative Time 9%
37. Ureter 9%
38. Colorectal Neoplasms 8%
39. Ureteroscopy 8%
40. Nephroureterectomy 8%
41. Cryosurgery 8%
42. Mortality 8%
43. Kidney Neoplasms 8%
44. Urinary Diversion 7%
45. Databases 7%
46. Placebos 7%
47. Confidence Intervals 7%
48. Stress Urinary Incontinence 7%
49. Percutaneous Nephrolithotomy 7%
50. Lymph Node Excision 7%
51. Warm Ischemia 7%
52. Wounds and Injuries 7%
53. Serum 7%
54. Castration 7%
55. Genome-Wide Association Study 7%
56. Urinary Tract Infections 7%
57. Protein-Tyrosine Kinases 7%
58. Androgens 6%
59. Urologists 6%
60. Cohort Studies 6%
61. Quality of Life 6%
62. Urine 6%
63. Length of Stay 6%
64. Incidence 6%
65. Systematic Reviews 6%
66. Odds Ratio 6%
67. Single Nucleotide Polymorphism 6%
68. Stents 6%
69. Artificial Urinary Sphincter 6%
70. Neoplasm Grading 6%
71. Urology 6%
72. Guidelines 6%
73. Nephrons 6%
74. Radiotherapy 5%
75. Drug Therapy 5%
76. Androgen Receptors 5%
77. Morbidity 5%
78. Safety 5%
79. Multiparametric Magnetic Resonance Imaging 5%
80. Comorbidity 5%
81. Pediatrics 5%
82. Neoplasm Metastasis 5%
83. Population 5%
84. Digital Rectal Examination 5%
85. Learning Curve 5%
86. Pressure 5%
87. Magnetic Resonance Imaging 5%
88. Equipment and Supplies 5%
89. Margins of Excision 5%